| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SHTN1 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-09 |
| mRNA | PIR | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | CABYR | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | MAFG | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-09 |
| mRNA | CYP4F11 | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-09 |
| mRNA | AKR1B10 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-09 |
| mRNA | AVPI1 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | MTFMT | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-08 |
| mRNA | COA6 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | TMEM87A | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-08 |
